ArticlePloS one2022

Hormone replacement therapy is associated with reduced hepatocellular carcinoma risk and improved survival in postmenopausal women with hepatitis B: A nationwide long-term population-based cohort study.

Chun-Hsiang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.